We are live on ! Find out more
MS

Maven Securities Portfolio holdings

AUM $5.2B
1-Year Est. Return 44.01%
This Fund
S&P 500
This Quarter Est. Return
+21.1%
1 Year Est. Return
+44.01%
3 Year Est. Return
+102.83%
5 Year Est. Return
+136.18%
10 Year Est. Return
AUM
$1.21B
AUM Growth
-$248M
Cap. Flow
-$400M
Cap. Flow %
-32.99%
Top 10 Hldgs %
23.94%
Holding
810
New
297
Increased
109
Reduced
151
Closed
223

Sector Composition

Rank Sector Weight
1 Healthcare 13.03%
2 Technology 7.51%
3 Consumer Discretionary 5.23%
4 Financials 5.2%
5 Industrials 4.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
101
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$2.59M 0.21%
7,700
-166,300
-96% -$55.1M
COST icon
102
PUT
Costco
COST
$415B
$2.59M 0.21%
7,300
+100
+1% +$33.6K
CSX icon
103
CSX Corp
CSX
$98.6B
$2.56M 0.21%
+97,500
New +$2.41M
MA icon
104
PUT
Mastercard
MA
$477B
$2.53M 0.21%
7,400
+5,200
+236% +$1.69M
MNTA
105
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$2.52M 0.21%
+48,000
New +$1.99M
NTES icon
106
NetEase
NTES
$76.5B
$2.52M 0.21%
27,695
-955
-3% -$89.8K
SBG.U
107
DELISTED
Sandbridge Acquisition Corporation Units, each consisting of one share of Class A Common Stock and o
SBG.U
$2.5M 0.21%
+250,000
New +$2.5M
TFII icon
108
TFI International
TFII
$12.4B
$2.49M 0.21%
60,000
+2,500
+4% +$105K
ADBE icon
109
CALL
Adobe
ADBE
$89.5B
$2.48M 0.2%
5,000
+1,100
+28% +$512K
GILD icon
110
PUT
Gilead Sciences
GILD
$161B
$2.46M 0.2%
39,200
+7,600
+24% +$527K
ALLY icon
111
Ally Financial
ALLY
$13.1B
$2.36M 0.19%
93,928
+63,360
+207% +$1.42M
ADSK icon
112
PUT
Autodesk
ADSK
$44.3B
$2.36M 0.19%
10,100
-4,900
-33% -$1.16M
TXN icon
113
PUT
Texas Instruments
TXN
$255B
$2.34M 0.19%
16,500
-10,900
-40% -$1.48M
LYG icon
114
Lloyds Banking Group
LYG
$87.4B
$2.33M 0.19%
1,691,581
XBI icon
115
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$2.32M 0.19%
+20,573
New +$2.31M
FOXA icon
116
Fox Class A
FOXA
$23.2B
$2.28M 0.19%
+81,990
New +$2.17M
VNET
117
VNET Group
VNET
$2.05B
$2.25M 0.19%
+96,882
New +$2.26M
AMGN icon
118
PUT
Amgen
AMGN
$203B
$2.25M 0.19%
8,900
-7,000
-44% -$1.73M
PRCH icon
119
Porch Group
PRCH
$1.3B
$2.23M 0.18%
+200,000
New +$2.11M
V icon
120
Visa
V
$677B
$2.21M 0.18%
10,957
+9,699
+771% +$1.94M
ISRG icon
121
PUT
Intuitive Surgical
ISRG
$121B
$2.2M 0.18%
9,300
-6,600
-42% -$1.48M
VRTX icon
122
PUT
Vertex Pharmaceuticals
VRTX
$121B
$2.19M 0.18%
8,000
+2,900
+57% +$800K
DFHTU
123
DELISTED
Deerfield Healthcare Technology Acquisitions Corp. Unit
DFHTU
$2.14M 0.18%
+200,000
New +$2.11M
KRRO icon
124
Korro Bio
KRRO
$153M
$2.13M 0.18%
+2,222
New +$2.39M
PAYA
125
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
$2.07M 0.17%
+200,535
New +$2.11M

Similar funds

Maven Securities's Q3 2020 Portfolio in Review

As of Q3 2020, Maven Securities held 810 positions worth $1.21B, down 17% from $1.46B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Maven Securities withdrew a net $400M in Q3 2020, closing 223 positions and reducing 151 holdings. Its most notable exit was Agios Pharmaceuticals, an estimated $16M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 5.9% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Maven Securities opened a new position in Adaptive Biotechnologies worth $18M.

  • Maven Securities's largest Q3 2020 buy was Adaptive Biotechnologies: 375,000 shares worth $18M.
  • Maven Securities added most to Caesars Entertainment in Q3 2020, an estimated $16.2M increase.
  • Maven Securities's biggest Q3 2020 reduction was BHP, cutting an estimated $10.7M.
  • Maven Securities fully exited Agios Pharmaceuticals in Q3 2020, selling an estimated $16M.
  • Maven Securities's ten largest holdings make up 24% of its $1.21B portfolio in Q3 2020.
  • Maven Securities opened 297 new positions and closed 223 in Q3 2020.
  • Maven Securities's portfolio value fell 17% quarter-over-quarter to $1.21B.

Based on Maven Securities's 13F filing for Q3 2020, filed 13 Nov 2020.